NEW YORK, Dec. 8 (GenomeWeb News) - SurroMed said today that it has licenced Ingenuity Systems' Pathway Analysis, an application that maps relationships between proteins, genes, complexes, cells, tissues, drugs, and diseases.
Financial terms of the arrangement were not disclosed.
Ingenuity has recently licensed the Pathways Analysis system to the Genomics Institute of the Novartis Research Foundation, the Stanford Genome Technology Center, and GlaxoSmithKline, and recently signed a software distribution deal with investor Affymetrix.